Hsa-miR-7974 Suppresses Epstein-Barr Virus Reactivation by Directly Targeting <i>BZLF1</i> and <i>BRLF1</i>

Hsa-miR-7974 Suppresses Epstein-Barr Virus Reactivation by Directly Targeting <i>BZLF1</i> and <i>BRLF1</i>

Epstein-Barr virus (EBV) reactivation, a key factor in Epstein-Barr virus (EBV)-associated malignancies, is regulated by specific cellular microRNAs (miRNAs). This study investigated the role of Hsa-miR-7974 (miR-7974) in this process. miRNA sequencing revealed significant downregulation of miR-7974...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haotian Li, Hui Wang, Jiao Wang, Xuexin Lu, Jieqiong Zhang, Mingming Wang, Dongbo Yu, Ying Li, Shiwen Wang
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Viruses
Subjects:	Epstein-Barr virus hsa-miR-7974 lytic cycle reactivation
Online Access:	https://www.mdpi.com/1999-4915/17/5/594
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circular RNA hsa_Circ_0007552 inhibits lung adenocarcinoma proliferation, migration and invasion via the miR-7974/BAP1 axis
by: Yanping Lin, et al.
Published: (2025-08-01)

The role of EBV lytic genes in tumor development and progression
by: DENG Yizhang, et al.
Published: (2024-09-01)

Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein–Bar virus in host
by: Muhammad Naveed, et al.
Published: (2024-12-01)

Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, <i>LMP1</i> variants, and malignant tumors
by: K. V. Smirnova, et al.
Published: (2022-10-01)

Pharmacological Activities of <i>Zingiber officinale</i> Roscoe: Inhibition of HSA Protein Glycation, Structure Stability and Function Restoration
by: Mohd Wajid Ali Khan, et al.
Published: (2024-11-01)

Curcumin derivative C210 induces Epstein–Barr virus lytic cycle and inhibits virion production by disrupting Hsp90 function
by: Linli Chen, et al.
Published: (2024-11-01)

To explore the role of hsa_circ_0053004/hsa-miR-646/CBX2 in diabetic retinopathy based on bioinformatics analysis and experimental verification
by: Zheng Sha, et al.
Published: (2025-03-01)

Differential expression of hsa_circ_0064357 and hsa_circ_0064358 between oral squamous cell carcinoma and oral lichen planus
by: Roxana NADERI, et al.
Published: (2023-06-01)

Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl<sub>2</sub>(η<sup>6</sup>-<i>p</i>-cymene)(bph-κ<i>N</i>)] Complex
by: Stefan Perendija, et al.
Published: (2025-07-01)

Novel small non-coding RNAs of Epstein-Barr virus upregulated upon lytic reactivation aid in viral genomic replication and virion production
by: Sagarika Banerjee, et al.
Published: (2025-05-01)

Hsa_circ_0001492 regulates the hsa-miR-145-5p/ovarian carcinoma immunoreactive antigen domain 2 axis to promote the progression of lung adenocarcinoma
by: Yuanqiang He, et al.
Published: (2024-10-01)

Molecular profile of Epstein–Barr virus in representatives of four ethnic groups of Russia: virus types, <i>LMP1</i> gene variability and malignancies
by: K. V. Smirnova, et al.
Published: (2023-12-01)

Epstein–Barr virus and mechanisms of molecular carcinogenesis
by: A. D. Molchanov, et al.
Published: (2025-06-01)

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p
by: Qi Liu, et al.
Published: (2025-06-01)

Distribution and Clinical Impact of <i>Helicobacter pylori</i> Virulence Factors in Epstein–Barr-Virus-Associated Gastric Cancer
by: Jin Hee Noh, et al.
Published: (2025-06-01)

Diagnostic value of hsa_circ_0012138 in the chronic progression of obstructive nephropathy
by: Zhichao Huang, et al.
Published: (2025-07-01)

The PD-1/PD-L1 pathway and Epstein–Barr virus
by: Hui Wang, et al.
Published: (2025-06-01)

Serum Hsa_circ_0023919 is a Predictive Biomarker of Chemoresistance in CRC Treatment
by: Zhang L, et al.
Published: (2024-12-01)

Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression
by: Li Liu, et al.
Published: (2025-04-01)

Deciphering the role of hsa-piR-775 in primary ovarian insufficiency through FOXG1 modulation
by: Hui Ding, et al.
Published: (2025-12-01)

In silico Approach of Some Selected Manuka Honey Constituents as Epstein–Barr Virus (EBV) Nuclear Antigen 1 (EBNA1) Inhibitors
by: Achmad Chusnu Romdhoni, et al.
Published: (2023-12-01)

Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations
by: Feiying Meng
Published: (2021-06-01)

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
by: Anne Woellmer, et al.
Published: (2012-09-01)

RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease
by: Zhaochen Guo, et al.
Published: (2025-02-01)

Recent Progress in the Vaccine Development Against Epstein–Barr Virus
by: Yihao Dai, et al.
Published: (2025-06-01)

Hsa_circ_0020095 modulates chemoresistance of CRC in a PDO model
by: Xinyu Li, et al.
Published: (2025-05-01)

Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection
by: Chunxiang Ma, et al.
Published: (2025-01-01)

The persistence of Epstein-Barr virus in the gastric mucosa in patients with chronic <i>Helicobacter pylori</i>-induced gastritis with gastric erosions and the effect on the course of the disease depending on the therapy
by: E. E. Dubskaya, et al.
Published: (2021-11-01)

Characterization, Genomic Analysis and Application of Five Lytic Phages Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Li-Ping Zhang, et al.
Published: (2025-07-01)

Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program
by: E. N. Simovanyan, et al.
Published: (2016-04-01)

Hsa_circ_0005571 promotes the proliferation and invasion of colorectal cancer cells
by: Haipeng Ge, et al.
Published: (2025-08-01)

Isolation and Genomic Analysis of <i>Escherichia coli</i> Phage AUBRB02: Implications for Phage Therapy in Lebanon
by: Tasnime A. Abdo Ahmad, et al.
Published: (2025-04-01)

Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome
by: Leonardo Josué Castro-Muñoz, et al.
Published: (2025-08-01)

Epstein-Barr Virus and Opsoclonus Myoclonus Syndrome
by: J Gordon Millichap
Published: (2002-04-01)

Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis
by: Wang L, et al.
Published: (2025-07-01)

Isolation and Characterization of a Lytic Phage PaTJ Against <i>Pseudomonas aeruginosa</i>
by: Jiayu Gu, et al.
Published: (2024-11-01)

Epidemiology characteristics of Epstein-Barr virus among children in Hangzhou from 2019 to 2023
by: Chen Lin, et al.
Published: (2025-08-01)

Loss of RASGRP1 in humans impairs T‐cell expansion leading to Epstein‐Barr virus susceptibility
by: Sarah Winter, et al.
Published: (2018-01-01)

Hsa_circ_0010957 knockdown attenuates lipopolysaccharide-induced HK2 cell injury by regulating the miR-1224-5p/IRAK1 axis
by: Jiaojiao Pan, et al.
Published: (2021-09-01)

The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases
by: Natalia Morawiec, et al.
Published: (2025-06-01)